File No. 001-10581
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
AMENDMENT NO. 1
ON
FORM 8-A/A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Bentley Pharmaceuticals, Inc.
-------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Florida 59-1513162
---------------------- -----------------
(State of Incorporation (I.R.S. Employer
or Organization) Identification No.)
4830 West Kennedy Boulevard, One Urban Centre, Suite 550, Tampa, Florida 33609
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
<TABLE>
<S> <C>
If this Form relates to the registration If this Form relates to the registration
of a class of debt securities and is of a class of debt securities and is
effective upon filing pursuant to to become effective simultaneously with
General Instruction A(c)(1) please check the effectiveness of a concurrent regis-
the following box. [ ] tration statement under the Securities
Act of 1933 pursuant to General
Instruction A(c)(2), please check the
following box. [ ]
</TABLE>
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
Common Stock American Stock Exchange/Pacific Stock Exchange
- ------------------- ----------------------------------------------
Securities to be registered pursuant to Section 12(g) of the Act: None.
<PAGE>
Item 1. Description of Registrant's Securities to be Registered.
Information required by this Item 1 relating to the Registrant's
Common Stock is incorporated by reference to Amendment No. 2 to the Registrant's
Registration Statement on Form S-1 (File No. 33-65125) that was filed with the
Securities and Exchange Commission on February 12, 1996, under the section
captioned "Description of Securities" on page 49 of the prospectus contained
therein.
-2-
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities
Exchange Act of 1934, the registrant has duly caused this registration statement
to be signed on its behalf by the undersigned, thereto duly authorized.
BENTLEY PHARMACEUTICALS, INC.
Date: February 28, 1996 By: /s/ Michael D. Price
---------------------
Michael D. Price
Vice President and Chief Financial Officer
-3-
